Related references
Note: Only part of the references are listed.
Article
Infectious Diseases
Can Yue et al.
LANCET INFECTIOUS DISEASES
(2023)
Article
Medicine, General & Internal
Tanayott Thaweethai et al.
Summary: SARS-CoV-2 infection is associated with persistent, relapsing, or new symptoms or other health effects occurring after acute infection, known as postacute sequelae of SARS-CoV-2 infection (PASC), or long COVID. This study developed a definition of PASC based on self-reported symptoms and described the frequencies of PASC across cohorts, vaccination status, and number of infections.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2023)
Article
Cell Biology
Panke Qu et al.
Summary: This study demonstrates the nearly complete escape of XBB.1.5, CH.1.1, and CA.3.1 variants from neutralizing antibodies stimulated by mRNA vaccine or BA.4/5 wave infection, but neutralization can be rescued by a bivalent booster containing BA.5. CH.1.1 and CA.3.1 also show strong immune escape from monoclonal antibody S309. Furthermore, the spike proteins of XBB.1.5, CH.1.1, and CA.3.1 exhibit enhanced fusogenicity and processing compared to BA.2.
Article
Public, Environmental & Occupational Health
Kevin C. Ma et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
(2023)
Article
Virology
Eili Y. Klein et al.
Summary: In this study, a large cohort of Omicron-infected patients between September 2022 and mid-February 2023 was used to evaluate the likelihood of hospital admission or need for supplemental oxygen in XBB variant infections. The results showed no significant association between XBB or XBB.1.5 infections and hospital admissions, while older age groups, lack of vaccination, immunosuppression, and underlying heart, kidney, and lung disease were significantly associated with hospitalization.
JOURNAL OF CLINICAL VIROLOGY
(2023)
Article
Medicine, General & Internal
Tanayott R. Thaweethai et al.
Summary: This study aims to develop a definition of postacute sequelae of SARS-CoV-2 infection (PASC) using self-reported symptoms and analyze the frequencies of PASC across different cohorts, vaccination status, and number of infections. The results show that PASC is associated with various symptoms and around 10% of participants were PASC positive at 6 months after infection.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2023)
Review
Infectious Diseases
Joan B. Soriano et al.
Summary: People with COVID-19 might experience long-term symptoms known as long COVID or long-haul COVID. The lack of a standardized definition hinders the understanding and treatment of this condition. In a WHO-led Delphi process, a consensus definition was developed, stating that post-COVID-19 condition occurs in individuals with a history of SARS-CoV-2 infection, with symptoms lasting for at least 2 months and impacting everyday functioning. This common framework provides a foundation for future studies and therapy.
LANCET INFECTIOUS DISEASES
(2022)
Editorial Material
Medicine, General & Internal
Waqaar Shah et al.
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Article
Medicine, General & Internal
Bettina Hohberger et al.
Summary: COVID-19 clinical features are caused by SARS-CoV-2, acute infection management is a significant healthcare issue, and the development of long-Covid syndrome poses challenges for patients and physicians. LCS is associated with various characteristics, such as impaired capillary microcirculation, chronic fatigue syndrome, proinflammatory cytokines, and functional autoantibodies targeting GPCR-AAbs.
FRONTIERS IN MEDICINE
(2021)
